Last April, as the world fell to Covid-19, one Chinese company was there to offer a helping hand: BGI. But the line between the biotech giant and Beijing is increasingly blurry.
Listen to SupChina editor-at-large and Sinica podcast host Kaiser Kuo read this article.
On January 25, 2020, as the city of Wuhan headed into the world’s first Covid-19 lockdown, the Chinese billionaire Wang Jian arrived on one of the last incoming trains. Flanked by a small entourage of younger scientists, Wang exited the station wearing a mask, a light puffy jacket and a backpack. Thousands were fleeing the river port metropolis. But Wang came ready to work.
During the SARS
Exclusive longform investigative journalism, Q&As, news and analysis, and data on Chinese business elites and corporations. We publish China scoops you won't find anywhere else.
A weekly curated reading list on China from David Barboza, Pulitzer Prize-winning former Shanghai correspondent for The New York Times.
A daily roundup of China finance, business and economics headlines.
We offer discounts for groups, institutions and students. Go to our Subscriptions page for details.
Washington’s $370 billion Inflation Reduction Act was seen as a generational opportunity for miners in the U.S. as well as mineral rich trading partners. But almost two years later, the North American mining industry is in crisis and no closer to chipping away at China's dominance. What went wrong?
The academic explains why we need to look beyond the actions of the Chinese government to understand how and why China is shaping countries in the region.
Navigate China's Business Landscape with Confidence.